2m 2m 2m 2m 2m 2m 2m
VYOME HLDGS (HIND)
NASDAQ
$2.25-$0.010 (-0.44%)
Price as of Jun 03, 2026 7:15 PM EDT- $16.4MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
VYOME HLDGS (HIND)
$2.25-$0.010 (-0.44%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 319,714 -96.01% | 8.0M -7.74% | 8.7M -22.79% | 11.2M -17.35% | |
Cost of Revenue | 100,943 -96.58% | 2.9M -5.78% | 3.1M -29.47% | 4.4M -15.50% | |
Gross Profit | 218,771 -95.67% | 5.1M -8.85% | 5.5M -18.44% | 6.8M -18.52% | |
Sales and Marketing Expense | 2.4M -20.91% | 3.0M -60.37% | 7.5M -46.44% | 14.1M +53.77% | |
Research and Development Expense | -588,258 -67.37% | -1.8M -22.12% | -2.3M -8.75% | -2.5M +0.59% | |
Depreciation and Amortization Expense | 11,985 N/A | 0 -100.00% | 33,000 -98.19% | 1.8M +4.83% | |
Total Operating Expenses | 10.7M -16.53% | 12.8M -38.92% | 20.9M -60.62% | 53.2M -18.04% | |
Operating Profit | -10.5M +35.26% | -7.7M -49.76% | -15.4M -66.81% | -46.4M -17.96% | |
Interest Income | 90,987 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -113,000 -86.42% | |
Interest Income and Expense and Net | 90,987 N/A | 0 N/A | 0 +100.00% | -113,000 -86.42% | |
Total Nonoperating Income and Expense | -25,143 -113.03% | 193,000 +58.20% | 122,000 +1,009.09% | 11,000 +101.32% | |
Income before Taxes | -10.5M +47.41% | -7.1M -37.44% | -11.3M -75.67% | -46.6M -24.90% | |
Income Taxes | N/A N/A | 39,000 -25.00% | 52,000 +113.68% | -380,000 +258.49% | |
Extraordinary Items | N/A N/A | 800,000 N/A | N/A N/A | N/A N/A | |
Net Income | -10.3M +43.93% | -7.1M -37.38% | -11.4M -75.36% | -46.2M -25.38% | |
Net Income from Continuing Operations Applicable to Common | -10.3M +44.72% | -7.1M -37.73% | -11.4M -75.36% | -46.2M -25.38% | |
Basic EPS and Net Income | -4.86 -64.86% | -13.83 +624.08% | -1.91 -98.25% | -108.90 +2,078.00% | |
Diluted EPS and Net Income | -4.86 -64.86% | -13.83 +624.08% | -1.91 -98.25% | -108.90 +2,078.00% | |
Basic Weighted Average Shares | 2.2M +319.22% | 515,566 -91.34% | 6.0M +1,303.56% | 424,390 -96.57% | |
Diluted Weighted Average Shares | 2.2M +319.22% | 515,566 -91.34% | 6.0M +1,303.56% | 424,390 -96.57% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.0M +618.95% | 693,000 -84.46% | 4.5M +15.67% | 3.9M -83.07% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.0M +618.95% | 693,000 -84.46% | 4.5M +15.67% | 3.9M -83.07% | |
Total Current Assets | 5.4M +18.53% | 4.6M -55.44% | 10.3M +3.88% | 9.9M -67.24% | |
Accumulated Depreciation | 524,309 +368.13% | 112,000 +24.44% | 90,000 -72.81% | 331,000 -2.65% | |
Property and Plant and Equipment and Net | 46,393 +22.09% | 38,000 -36.67% | 60,000 -91.40% | 698,000 -51.99% | |
Total Long-Term Assets | 1.1M +3,551.23% | 29,000 0.00% | 29,000 -36.96% | 46,000 -96.84% | |
Total Assets | 6.5M +35.56% | 4.8M -55.05% | 10.7M -4.30% | 11.1M -79.46% | |
Income Taxes Payable | N/A N/A | 30,000 -50.82% | 61,000 -83.38% | 367,000 -33.87% | |
Total Short-Term Debt | N/A N/A | 811,000 N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.7M -45.13% | 5.0M +31.98% | 3.8M -49.51% | 7.5M +2.05% | |
Total Long-Term Debt | 3.0M N/A | N/A N/A | N/A N/A | 10.0M +9.08% | |
Total Long-Term Liabilities | 2.5M +3,979.95% | 61,000 -72.65% | 223,000 -69.62% | 734,000 -42.34% | |
Total Liabilities | 2.7M -45.80% | 5.0M +26.15% | 4.0M -46.53% | 7.5M -8.61% | |
Retained Earnings | -87.6M -86.38% | -642.7M +1.12% | -635.6M +1.82% | -624.2M +8.22% | |
Total Stockholders Equity | 3.8M +1,586.96% | -253,000 -103.80% | 6.7M +82.00% | 3.7M -92.05% | |
Total Shares Outstanding | 5.9M +710.89% | 729,980 -96.89% | 23.5M +4,417.76% | 519,219 -97.09% | |
Cash Flow | |||||
Cash from Operating Activities | -3.7M -15.32% | -4.4M -73.90% | -17.0M -22.56% | -21.9M +42.45% | |
Capital Expenditures | N/A N/A | 43,000 0.00% | 43,000 -67.18% | 131,000 -62.78% | |
Cash from Investing Activities | N/A N/A | -10,000 0.00% | -10,000 -89.13% | -92,000 -104.96% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.7M +1,178.43% | 677,000 -96.15% | 17.6M +461.47% | 3.1M -90.60% | |
Financials Ratio | |||||
Gross Margin | 68.43% +8.33% | 63.17% -1.20% | 63.93% +5.64% | 60.52% -1.41% | |
Operating Margin | -3,269.35% +3,286.96% | -96.53% -45.55% | -177.26% -57.01% | -412.38% -0.74% | |
Return on Assets | -181.79% +97.03% | -92.26% -11.66% | -104.44% -26.10% | -141.33% -25.98% | |
Return on Equity | -584.89% +162.91% | -222.46% +0.85% | -220.59% +18.70% | -185.85% -23.87% | |
Revenue Growth | -96.01% +1,139.80% | -7.74% -66.03% | -22.79% +31.35% | -17.35% -102.29% | |
Current Ratio | 1.99 +116.03% | 0.92 -66.24% | 2.73 +105.77% | 1.32 -67.90% | |
Cash Ratio | 1.82 +1,210.50% | 0.14 -88.23% | 1.18 +129.11% | 0.52 -83.41% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow